The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
In myelofibrosis, combinations of rufolitinib reduce spleen volume.
2.
Treatment of Oligometastatic EGFR-Mutant Lung Cancer
3.
Aster Whitefield Hospital, with 506 beds, opened.
4.
New First-Line Option for Advanced ALK-Positive Lung Cancer
5.
AI Model Has Promise for Predicting Checkpoint Inhibitor Activity in NSCLC
1.
Unveiling the Hidden Dangers of Hand Cancer: How to Protect Yourself
2.
Late Effects of Immunotherapy in Chronic Melanoma Survivorship with Repurposed Drugs
3.
Stomach Cancer: Uncovering the Subtle Signs and Symptoms
4.
All You Need to Know About Mesna: The Ultimate Guide
5.
Beating Cancer Fatigue The Most Effective Exercise Strategies for Breast Cancer Survivors
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
2.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
5.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation